# Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study

Study · id `cardio:ct-nct01700322` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01700322](<https://clinicaltrials.gov/study/NCT01700322>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01700322

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.

## Technical summary

Registry record NCT01700322. Randomized; single masking; primary purpose basic science. Start 2012-08 (registry gives no type); primary completion 2016-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose basic science
- Phase: Phase 4
- Enrolled: 126 participants (enrolled count; ClinicalTrials.gov record NCT01700322, source copy `cardio:ctgov-nct01700322-2016-09-07`, retrieved 2026-10-26)
- Start date: 2012-08 (registry gives no type) (ClinicalTrials.gov record NCT01700322, source copy `cardio:ctgov-nct01700322-2016-09-07`, retrieved 2026-10-26)
- Primary completion: 2016-07 (actual) (ClinicalTrials.gov record NCT01700322, source copy `cardio:ctgov-nct01700322-2016-09-07`, retrieved 2026-10-26)
- Completion: 2016-09 (actual) (ClinicalTrials.gov record NCT01700322, source copy `cardio:ctgov-nct01700322-2016-09-07`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT01700322, source copy `cardio:ctgov-nct01700322-2016-09-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01700322-2016-09-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor Study
- Acronym: EST
- Condition: Coronary Artery Disease
- Intervention (Procedure): Coronary stenting
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Prasugrel
- Lead sponsor: Johannes Gutenberg University Mainz
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)
- Registry lists this organization as the lead sponsor: Johannes Gutenberg University Mainz (`cardio:org-johannes-gutenberg-university-mainz`)

## Provenance

Content hash: 8d9b2e3d05ad701d838a7f1197b9100379b216ec8ee4814310828c84c2cc9a30
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
